Up-front blinatumomab improves MRD clearance and outcome in adult Ph– B-lineage ALL: the GIMEMA LAL2317 phase 2 study
Renato Bassan(Pittini Group (Italy)), Robin Foà(Sapienza University of Rome), Francesco Grimaldi, Mariangela Di Trani(Sapienza University of Rome), Orietta Spinelli(Ospedale Papa Giovanni XXIII), Paola Fazi(Fondazione Gimema Onlus), Monica Messina(Fondazione Gimema Onlus), Mario Tiribelli(University of Udine), Matteo Leoncin(Ospedale dell' Angelo), Erika Borlenghi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Mario Annunziata(Ospedale Antonio Cardarelli), Francesco Di Raimondo(University of Catania), Monica Bocchia(University of Siena), Sabina Chiaretti(Sapienza University of Rome), Alfonso Piciocchi(Fondazione Gimema Onlus), Patrizia Chiusolo(Agostino Gemelli University Polyclinic), Alessandra Santoro(Ospedale Vincenzo Cervello), Federico Lussana(Ospedale Papa Giovanni XXIII), Monia Lunghi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Albana Lico(Ospedale San Bortolo), Patrizia Zappasodi(Policlinico San Matteo Fondazione), Irene Della Starza(Associazione Italiana Ematologia Oncologia Pediatrica), Catello Califano(Presidio Ospedaliero), Deborah Cardinali(Sapienza University of Rome), Matteo Piccini(Azienda Ospedaliero-Universitaria Careggi), Ernesta Audisio(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Anna Maria Mianulli(Azienda Unità Sanitaria Locale Della Romagna), Manuela Tosi(Ospedale Papa Giovanni XXIII), Maria Stefania De Propris(Sapienza University of Rome), Valentina Arena(Fondazione Gimema Onlus), Loredana Elia(Sapienza University of Rome), Anna Candoni(University of Udine)
Cited by 37
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644